Skip to main content
Advertisement
Advertisement

OSCR

OSCR logo

Oscar Health, Inc.

32.42
USD
Sponsored
+1.48
+4.78%
Oct 05, 16:00 UTC -4
Closed
exchange

After-Market

32.58

+0.16
+0.50%

OSCR Earnings Reports

Positive Surprise Ratio

OSCR beat 12 of 22 last estimates.

55%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$4.82B
/
-$0.24
Implied change from Q2 26 (Revenue/ EPS)
-1.28%
/
-121.82%
Implied change from Q3 25 (Revenue/ EPS)
+61.34%
/
-54.72%

Oscar Health, Inc. earnings per share and revenue

On Aug 06, 2026, OSCR reported earnings of 1.10 USD per share (EPS) for Q2 26, beating the estimate of 0.39 USD, resulting in a 179.54% surprise. Revenue reached 4.88 billion, compared to an expected 4.85 billion, with a 0.71% difference. The market reacted with a -11.86% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 4.82 billion USD, implying an decrease of -121.82% EPS, and decrease of -1.28% in Revenue from the last quarter.
FAQ
For Q2 2026, Oscar Health, Inc. reported EPS of $1.10, beating estimates by 179.54%, and revenue of $4.88B, 0.71% above expectations.
The stock price moved down -11.86%, changed from $30.11 before the earnings release to $26.54 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 10 analysts, Oscar Health, Inc. is expected to report EPS of -$0.24 and revenue of $4.82B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement